- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Glenmark Pharmaceuticals Limited — Updates, 20-02-2026: General Updates
20-02-2026 | 05:29 pm
20-02-2026 | 05:29 pm
Glenmark Pharma has received an ESG rating of 68 for FY25 from NSE Sustainability. This rating, based on public data, was assigned independently, not via company engagement.
No comments yet. Be the first to comment!